| Oct 28 |
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
|
| Oct 28 |
Inari Medical GAAP EPS of -$0.31, revenue of $153M
|
| Oct 28 |
Inari Medical Reports Third Quarter 2024 Financial Results
|
| Oct 28 |
Inari Medical Q3 2024 Earnings Preview
|
| Oct 23 |
Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 21 |
Okami Medical Announces Closing Of $32.5M Financing
|
| Oct 21 |
Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for
|
| Oct 15 |
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
|
| Oct 9 |
Inari Medical Inc (NARI) Q2 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges
|
| Oct 7 |
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
|
